Effects of melatonin on suppression of renal scarring in experimental model of pyelonephritis

Mustafa Imamoğlu1, Ali Cay, Umit Cobanoglu

  • 1Department of Pediatric Surgery, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey. mimamoglu61@yahoo.com

Urology
|May 16, 2006
PubMed
Abstract

Insights

Melatonin combined with antibiotics significantly reduces kidney damage and scarring in a pyelonephritis rat model. This combination therapy inhibits malondialdehyde production and neutrophil infiltration, offering a protective effect against renal damage.

Area of Science:

  • Nephrology
  • Pharmacology
  • Experimental Pathology

Background:

  • Pyelonephritis can lead to renal scarring and long-term kidney damage.
  • Antibiotic therapy is standard for pyelonephritis, but renal scarring can still occur.
  • Melatonin's antioxidant and anti-inflammatory properties suggest a potential role in mitigating kidney injury.

Purpose of the Study:

  • To investigate the efficacy of combined melatonin and antibiotic treatment in preventing renal scarring in an experimental pyelonephritis model.
  • To assess the impact of this combination therapy on oxidative stress markers and inflammatory responses.

Main Methods:

  • An experimental pyelonephritis model was established in rats via direct bacterial inoculation.
  • Treatment groups included no treatment, antibiotic (ceftriaxone) only, melatonin only, and antibiotic plus melatonin.
  • Kidney tissues were analyzed for malondialdehyde levels and histopathological changes (inflammation and scarring) after 6 weeks.

Main Results:

  • Combined antibiotic and melatonin treatment significantly reduced malondialdehyde levels compared to untreated and antibiotic-only groups.
  • Histopathological examination showed no significant difference in renal scarring scores between the combined treatment group and the control group.
  • Melatonin alone also reduced malondialdehyde levels, but did not significantly impact scarring scores compared to controls.

Conclusions:

  • Combination therapy with melatonin and antibiotics effectively prevents renal scarring in experimental pyelonephritis.
  • Melatonin's inhibition of malondialdehyde production and neutrophil infiltration contributes to its protective effect against antibiotic-induced renal damage.
  • This combination therapy holds promise for improving outcomes in pyelonephritis patients by reducing long-term kidney damage.